Novo Nordisk and Vivtex Corporation have entered into a partnership to develop next-generation oral biologic medicines for ...
Novo Nordisk is suing a Shrewsbury doctor who sells a cheaper compounded medicine version of its popular Ozempic and Wegovy weight-loss drugs.
Novo Nordisk announced plans to drastically reduce the list price of its versions, Wegovy, Ozempic and Rybelsus.
Hosted on MSN
Novo-aktie stiger pænt efter pillegodkendelse i USA
Der har været langt mellem de gode nyheder for Novo Nordisk i 2025, men på en af årets sidste handelsdage stiger kursen på medicinalaktien betragteligt. Tirsdag handles Novo-aktien således 7,3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results